PT Diastika Biotekindo Tbk (ISX:CHEK) PS Ratio: 1.66 (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:CHEK PT Diastika Biotekindo Tbk ISX:CHEK
2 GF Score
Price Rp129.00
! 1 Warning Sign
View Full Analysis

What is PT Diastika Biotekindo Tbk PS Ratio?

PT Diastika Biotekindo Tbk ISX:CHEK -0.77% 2 PS Ratio is 1.66 as of Sep. 21, 2026. GuruFocus rates ISX:CHEK with a GF Score™ of 2/100. The stock has 1 warning sign investors should review. Among 122 Medical Distribution companies, PT Diastika Biotekindo Tbk ranks worse than 819671.31% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PT Diastika Biotekindo Tbk's share price is Rp129.00. PT Diastika Biotekindo Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was Rp77.50. Hence, PT Diastika Biotekindo Tbk's PS Ratio for today is 1.66.

The historical rank and industry rank for PT Diastika Biotekindo Tbk's PS Ratio or its related term are showing as below:

ISX:CHEK's PS Ratio is not ranked *
in the Medical Distribution industry.
Industry Median: 0.47
* Ranked among companies with meaningful PS Ratio only.

PT Diastika Biotekindo Tbk's Revenue per Sharefor the three months ended in Jun. 2026 was Rp11.16. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was Rp77.50.

Back to Basics: PS Ratio


PT Diastika Biotekindo Tbk  (ISX:CHEK) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


PT Diastika Biotekindo Tbk PS Ratio Related Terms


PT Diastika Biotekindo Tbk PS Ratio Historical Data

* Premium members only.

The historical data trend for PT Diastika Biotekindo Tbk's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diastika Biotekindo Tbk PS Ratio Chart

PT Diastika Biotekindo Tbk Annual Data
Trend Dec22 Dec23 Dec24 Dec25
PS Ratio
- - - 4.33

PT Diastika Biotekindo Tbk Quarterly Data
Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PS Ratio Get a 7-Day Free Trial - 13.63 2.59 1.76 1.56

ISX:CHEK vs MCK, COR, CAH: PS Ratio Comparison

For the Medical Distribution subindustry, PT Diastika Biotekindo Tbk's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Diastika Biotekindo Tbk PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Diastika Biotekindo Tbk's PS Ratio distribution charts can be found below:

* The bar in red indicates where PT Diastika Biotekindo Tbk's PS Ratio falls into.


ISX:CHEK
2GF Score
PT Diastika Biotekindo Tbk ISX:CHEK
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Diastika Biotekindo Tbk PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

PT Diastika Biotekindo Tbk's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=129.00/77.496
=1.66

PT Diastika Biotekindo Tbk's Share Price of today is Rp129.00.
PT Diastika Biotekindo Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp77.50.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 1.66 mean?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a PS Ratio of 1.66 as of Sep. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PT Diastika Biotekindo Tbk and its competitors. According to the industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 122 companies in the Medical Distribution industry.
Is PT Diastika Biotekindo Tbk's PS Ratio too high?
PT Diastika Biotekindo Tbk's current PS Ratio is 1.66. The Medical Distribution industry median PS Ratio is 0.47. PT Diastika Biotekindo Tbk's value of 1.66 is 253.2% above this industry median. Based on the distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 122 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, PT Diastika Biotekindo Tbk has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does PT Diastika Biotekindo Tbk's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 122 companies for PS Ratio. This places PT Diastika Biotekindo Tbk in the lower half of its industry. The industry median PS Ratio is 0.47. PT Diastika Biotekindo Tbk's value of 1.66 is 253.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.47, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Diastika Biotekindo Tbk's current PS Ratio of 1.66 is 253.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PT Diastika Biotekindo Tbk and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Diastika Biotekindo Tbk's current PS Ratio is 1.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current PS Ratio of 1.66. The current PS Ratio is 1.66 and 253.2% above the Medical Distribution industry median of 0.47. PT Diastika Biotekindo Tbk's overall GF Score™ is 2/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current PS Ratio is 1.66 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diastika Biotekindo Tbk Business Description

Address Jalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.
2GF Score

Get the complete analysis for ISX:CHEK

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp129.00
Price